MedTrace Logo

A Study on the Effects of Soy Protein on Blood Lipids in Men and Women With Mild to Moderate Hypercholesterolemia

NCT00945737 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2012-06-07

No results posted yet for this study

Summary

The objectives of the trial are to determine whether a non-commercial soy protein product, consumed as part of a low-saturated fat diet, reduces low-density lipoprotein cholesterol (LDL-C) concentrations in men and women with mild to moderate hypercholesterolemia, and affects other aspects related biomarkers.

Conditions

Interventions

DIETARY_SUPPLEMENT

Soy protein; 25 grams/day

Soy protein

DIETARY_SUPPLEMENT

Control protein

Milk protein

Sponsors & Collaborators

  • Solae, LLC

    lead INDUSTRY

Principal Investigators

  • Matthew Reeves, DO · Provident Clinical Research

  • Mano Patri, MD · Provident Clinical Research, Addison, IL

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2009-08-31
Completion
2009-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00945737 on ClinicalTrials.gov